
methylglutaryl-CoA reductase degradation in yeast J. Biol. Chem. 276: 8681-8694. (PubMed)
E.S. Istvan and J. Deisenhofer. 2001. Structural mechanism for statin inhibition of HMG-CoA reductase Science 292:
1160-1164. (PubMed)
G.C. Ness and C.M. Chambers. 2000. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl
coenzyme A reductase: The concept of cholesterol buffering capacity Proc. Soc. Exp. Biol. Med. 224: 8-19. (PubMed)
P. Libby, M. Aikawa, and U. Schonbeck. 2000. Cholesterol and atherosclerosis Biochim. Biophys. Acta 1529: 299-309.
(PubMed)
S. Yokoyama. 2000. Release of cellular cholesterol: Molecular mechanism for cholesterol homeostasis in cells and in the
body Biochim. Biophys. Acta 1529: 231-244. (PubMed)
S.R. Cronin, A. Khoury, D.K. Ferry, and R.Y. Hampton. 2000. Regulation of HMG-CoA reductase degradation requires
the P-type ATPase Cod1p/Spf1p J. Cell Biol. 148: 915-924. (PubMed)
P.A. Edwards, D. Tabor, H.R. Kast, and A. Venkateswaran. 2000. Regulation of gene expression by SREBP and SCAP
Biochim. Biophys. Acta 1529: 103-113. (PubMed)
E.S. Istvan, M. Palnitkar, S.K. Buchanan, and J. Deisenhofer. 2000. Crystal structure of the catalytic portion of human
HMG-CoA reductase: Insights into regulation of activity and catalysis EMBO J. 19: 819-830. (PubMed)
L. Tabernero, D.A. Bochar, V.W. Rodwell, and C.V. Stauffacher. 1999. Substrate-induced closure of the flap domain in
the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA
reductase Proc. Natl. Acad. Sci. USA. 96: 7167-7171. (PubMed) (Full Text in PMC)
D. Fass, S. Blacklow, P.S. Kim, and J.M. Berger. 1997. Molecular basis of familial hypercholesterolaemia from structure
of LDL receptor module Nature 388: 691-693. (PubMed)
H. Jeon, W. Meng, J. Takagi, M.J. Eck, T.A. Springer, and S.C. Blacklow. 2001. Implications for familial
hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair Nat. Struct. Biol. 8: 499-504.
(PubMed)
Lipoproteins and their receptors
C.G. Brouillette, G.M. Anantharamaiah, J.A. Engler, and D.W. Borhani. 2001. Structural models of human
apolipoprotein A-I: A critical analysis and review Biochem. Biophys. Acta 1531: 4-46. (PubMed)
T. Hevonoja, M.O. Pentikainen, M.T. Hyvonen, P.T. Kovanen, and M. Ala-Korpela. 2000. Structure of low density
lipoprotein (LDL) particles: Basis for understanding molecular changes in modified LDL Biochim. Biophys. Acta 1488:
189-210. (PubMed)
D.L. Silver, X.C. Jiang, T. Arai, C. Bruce, and A.R. Tall. 2000. Receptors and lipid transfer proteins in HDL metabolism
Ann. N. Y. Acad. Sci. 902: 103-111. (PubMed)
J. Nimpf and W.J. Schneider. 2000. From cholesterol transport to signal transduction: Low density lipoprotein receptor,
very low density lipoprotein receptor, and apolipoprotein E receptor-2 Biochim. Biophys. Acta 1529: 287-298. (PubMed)
D.W. Borhani, D.P. Rogers, J.A. Engler, and C.G. Brouillette. 1997. Crystal structure of truncated human apolipoprotein
A-I suggests a lipid-bound conformation Proc. Natl. Acad. Sci. USA. 94: 12291-12296. (PubMed) (Full Text in PMC)
C. Wilson, M.R. Wardell, K.H. Weisgraber, R.W. Mahley, and D.A. Agard. 1991. Three-dimensional structure of the
LDL receptor-binding domain of human apolipoprotein E Science 252: 1817-1822. (PubMed)
A.S. Plump, J.D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992.
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous